A Self‐Propelled DNA‐Based Nanorobot for Hypoxic Tumor Therapy
Angewandte Chemie International Edition · 09.11.2026 · 65 (46)
DOI: 10.1002/anie.7173496 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 26.09.2026. Verfasst von Qin Fan und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Flexible Electronics (LoFE), Jiangsu Key Laboratory of Smart Biomaterials and Theranostic Technology, Institute of Advanced …. Hauptthemen laut MEDLINE: DNA, Methylene Blue, Antineoplastic Agents, Neoplasms. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Nature Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Solid tumors pose major therapeutic hurdles due to pathophysiological barriers such as hypoxia and dense stroma, which severely restrict drug penetration. Conventional nanomedicines lack the autonomous capability to navigate these evolving obstacles. Here, we engineer a DNA‑based nanorobot constructed on an optimized tetrahedral framework nucleic acid (tFNA) that co‑assembles tumor‑targeting aptamers, catalytic platinum nanoparticles (Pt‑NPs), and the therapeutic payload methylene blue (MB) into a single modular platform. This integrated design enables three coordinated functions: tumor‑specific recognition, self‑propelled transport driven by oxygen generation, and concurrent hypoxia alleviation to potentiate photodynamic therapy (PDT) in hypoxic tumors. The Pt‐NPs catalyze the decomposition of overproduced hydrogen peroxide (H 2 O 2 ) in the tumor microenvironment, generating oxygen bubbles that both drive deep tissue penetration (to depths > 300 µm) and alleviate local hypoxia. This self‑powered propulsion enables efficient delivery of MB, leading to cascaded PDT activation. In vivo, the nanorobot achieves 85% tumor regression through the coordinated actions of deep penetration, hypoxia relief, and enhanced PDT. This modular DNA nanoplatform provides a promising strategy for advanced nanomedicine by autonomously addressing key delivery barriers in solid tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Flexible Electronics (LoFE), Jiangsu Key Laboratory of Smart Biomaterials and Theranostic Technology, Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, N…
- School of Chemistry and Chemical Engineering, New Cornerstone Science Laboratory, Frontiers Science Center for Transformative Molecules, National Center for Translational Medicine, Zhangjiang Institute for Advanced Stud…
ORCID-Profile: Qin Fan, Chunhai Fan, Lianhui Wang, Jie Chao
Förderung
- National Key Research and Development Program of China
- National Nature Science Foundation of China
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Fan, Q., Yao, X., Sun, B., Lu, Z., Xie, M., Fan, C., Wang, L., & Chao, J. (2026). A Self‐Propelled DNA‐Based Nanorobot for Hypoxic Tumor Therapy. Angewandte Chemie International Edition, 65(46). https://doi.org/10.1002/anie.7173496
Vancouver
Fan Q, Yao X, Sun B, Lu Z, Xie M, Fan C, et al. A Self‐Propelled DNA‐Based Nanorobot for Hypoxic Tumor Therapy. Angewandte Chemie International Edition. 2026;65(46). doi:10.1002/anie.7173496
BibTeX
@article{Fan2026,
author = {Fan, Qin and Yao, Xinhao and Sun, Bichen and Lu, Zhenyu and Xie, Mo and Fan, Chunhai and Wang, Lianhui and Chao, Jie},
title = {A Self‐Propelled DNA‐Based Nanorobot for Hypoxic Tumor Therapy},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {46},
doi = {10.1002/anie.7173496}
}
EUVIMED